SEC Filings TLDR Banner

Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.

Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.

Filter by Form Type:
All346-K8-K10-Q144Schedule 13GSchedule 13G/ASchedule 13DSchedule 13D/A
Industry:Biotechnologyβœ•
Previous Page1213141516171819Next Page
2026-04-23CANF3SEC Filing Summary for Can-Fite BioPharma Ltd. - Officer/Director ChangeMEDIUM
This filing details a Form 3, Initial Statement of Beneficial Ownership, for Ilan Tamir, a director at Can-Fite BioPharma Ltd. The report, dated March 18, 2026, indicates that Tamir holds options to purchase 16,000 ordinary shares. These options are not currently vested and will vest in sixteen equal quarterly installm...
Nano CapBiotechnology
2026-04-22ARDX3
Small CapBiotechnology
2026-04-22ARDELYX, INC.3Duplicate
Small CapBiotechnology
Previous Page1213141516171819Next Page